The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer
Version of Record online: 29 MAR 2011
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL
Volume 108, Issue 8, pages 1262–1268, October 2011
How to Cite
Schiavina, R., Manferrari, F., Garofalo, M., Bertaccini, A., Vagnoni, V., Guidi, M., Borghesi, M., Baccos, A., Morselli-Labate, A. M., Concetti, S. and Martorana, G. (2011), The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer. BJU International, 108: 1262–1268. doi: 10.1111/j.1464-410X.2010.10016.x
- Issue online: 29 SEP 2011
- Version of Record online: 29 MAR 2011
- Accepted for publication 1 October 2010
- 14AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002, , et al.
- 16NCCN Clinical Practice Guidelines in OncologyTM: Prostate Cancer. Version 2.2007, 04/09/07 © 2007 National Comprehensive Cancer Network
- 21Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 2009; 55: 261–70, , et al.
- 26Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy. BJU Int 2007; 99: 315–20, , , , .
- 28Improved sensitivity for detecting micrometastases in pelvic lymph nodes by real-time reverse transcriptase polymerase chain reaction (RT-PCR) compared with conventional RT-PCR in patients with clinically localized prostate cancer undergoing radical prostatectomy. BJU Int 2009; 103: 1074–8, , , , , .